Coronary arteriovenous fistulae (CAVF) are a major coronary anomaly, being present in 0.002% of the general population and was first described by Krause in 1865.
1
Coronary anomalies may be abnormalities of origin, distribution, or termination. CAVF are considered mainly to be termination abnormalities. 5, 6 Nomenclature is based upon a descriptive analysis of the vessel of origin and the chamber of termination. According to Sakakibara et al, there are two types of angiographic classification: Type A-proximal type, where the proximal coronary segment is dilated to the origin of the fistula and the distal end is normal; and Type B-distal type, where the coronary artery is dilated over its entire length terminating as a fistula mainly into the right side of the heart (end-artery type) and the proximal coronary segment can or might have regular branches. 6 Each one of these groups can be presented with different clinical signs and symptoms.
6,7

Epidemiology
The incidence of coronary anomalies is 0.2 to 1.2% of the population.
Complications owing to CAVF are present in 11% of the patients younger than 20 years and in 35% of the patients older than 20 years.
12,13
Multiple fistulae are present in 10.7 to 16% of all CAVF with single fistulae being far more common occurring in up to 90% of the cases. 3, 8, 14, 15 CAVF are visualized in nearly 0.25% of the patients undergoing catheterization and there is no race or sex predilection. 6, 8, 9, 16, 17 In other studies, CAVF have also been reported in approximately 0.3% of patients presented with congenital heart disease, 0.06% of children undergoing echocardiography, and 0.13 to 0.22% of adults undergoing coronary angiography.
18
►Table 1 shows the percentage of fistulae originating from each one of the coronary arteries, and the percentage drained in each one of the cardiac chambers, great vessels, and coronary sinus. 6 Etiology CAVF are primarily congenital, but they can be acquired in rare occasions. Acquired causes can be further subclassified into disease related, iatrogenic, and traumatic (►Table 2).
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Morphology
The arterial tree can communicate with a cardiac chamber or great vessel in the following two ways: either with the right side of the circulation (right atrium and its tributaries, coronary sinus, right ventricle, pulmonary artery) causing a leftto-right shunt; or with the left atrium or left ventricle causing an arterial runoff. The former is more frequent.
20
The feeding artery of the fistula may drain from a coronary artery or one of its branches and it is usually dilated and tortuous. The more proximal the origin from the main coronary artery the more dilated the feeding artery tends to be and the more distal the origin the more tortuous it appears to be. Fistulae originating from the left coronary artery and draining into the left ventricle tend to be particularly tortuous, presenting a challenge for transcatheter closure (TCC). Finally, there may be multiple feeding arteries to a single drainage point, and multiple drainage sites may exist.
Pathophysiology
Coronary "steal phenomenon" is believed to be the primary pathophysiological problem seen in CAVF without outflow obstruction. The mechanism is related to the runoff from the high-pressure coronary vasculature to a low-resistance receiving cavity (e.g., pulmonary vasculature) due to a diastolic pressure gradient. Eventually, there is a high risk of ischemia in the myocardium beyond the site of the origin of the fistula, which is most frequently evident in association with increased myocardial oxygen demand during exercise or activity.
3 Normal thin-walled vessels exist at the arteriolar level that may drain into the heart (arteriosinusoidal vessels) and venous communications (thebesian veins) to the right atrium. These small vessels do not steal significant nutrient flow and do not constitute fistulous connections. Fistulae can be large (> 250 mm) and dilated or ectatic, and they tend to enlarge over time. Note: Low-pressure structures, such as the right chambers of the heart and the pulmonary artery are the most common sites of drainage. On the contrary, Angelini et al have concluded against this pathophysiological mechanism as a cause of critical ischemia because of the following reasons: (1) only a few coronary fistulae cause chest pain or reversible ischemia during functional testing, (2) at the fistulous site, there is favorable readjustment of the nutrient fistulous flow ratio following exercise, despite the vasodilatation of the nutrient branches, and (3) under resting conditions, a myocardial infarction, resting chest pain, or hibernation would only be caused secondary to a significant coronary steal phenomenon; something that has not yet been reported.
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19,22
The possible complications of CAVF are coronary artery dilatation, aneurysm formation, intimal ulceration, medial degeneration, intimal rupture, atherosclerotic deposition, calcification, side-branch obstruction, mural thrombosis, and rupture.
3 A left-to-right shunt exists in over 90% of cases.
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Clinical Presentation
It is commonly believed that the lesion is incidentally detected on routine examination or during coronary angiography. 23 Small fistulae are asymptomatic but in the large ones symptoms may be present before 20 years of age. 24 In fact, large fistulae have been seen to be associated with presentation of signs of congestive heart failure, especially in infancy.
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Generally, the symptoms develop depending on the amount of the left-to-right shunt or the presence of coronary steal phenomenon of the fistulae, which usually present in young adults with angina (3-7%), exertional dyspnoea (60%), endocarditis in the fistula (20%), syncope, palpitations, myocardial ischemia and infarction, and manifest in older adults with congestive heart failure (19%), atherosclerosis, and cardiac arrhythmias.
25,26
Angina pectoris occurs as a result of the coronary "steal phenomenon" where there is blood shunting and perfusion away from the myocardium. This may be a cause for the development of a coronary artery aneurysmal change.
Symptoms of congestive heart failure may result when the fistula drains into the right system resulting in congestion and pulmonary hypertension.
11 Such symptoms are common, particularly in neonates and infants who present with large fistulae that result in a large volume shunt. 18 The fistula may rupture spontaneously, causing hemopericardium and cardiac tamponade. 9 Rarely, sudden death can occur, especially in young patients, as in the case of a 7-year-old patient who had acute pulmonary edema after anesthesia.
27,28
The predominant physical finding is a continuous murmur, representing the systolic-diastolic flow in large fistulae.
29,30
CAVF, especially in asymptomatic patients, are usually suspected when a murmur is detected. Pediatric patients with fistulae are often brought into attention following presentation of an unexplained murmur. 18 The murmur is heard the loudest on the chest wall depending on where the fistula enters the heart, its character is soft at a grade of 2/6 to 4/6; it is also continuous and tends to be crescendodecrescendo, in both systole and diastole. It is however louder in diastole.
4
A smaller percentage of pediatric patients tend to be asymptomatic, unlike adults. Associated congenital cardiovascular anomalies have been reported in the literature in 5 to 30% of cases such as atrial septal defect, Tetralogy of Fallot, ventricular septal defect, and patent ductus arteriosus.
3,31
Diagnostic Approach
Physical examination is very important as the signs mentioned above in Section 5 will indicate further investigation with imaging.
Angelini suggested a very useful screening and treatment guideline (►Fig. 1).
32 According to this approach, a nonathlete with mild symptoms should initially be investigated with an electrocardiograph (ECG) and a chest X-ray (CXR). Should these be negative, no additional investigations are required and if positive, an echocardiogram (Echo), a treadmill test (TMT), and heart catheterization with intravascular ultrasound scan (IVUS) should follow. In an athlete with mild symptoms, initial approach should include ECG, CXR, Echo, TMT, and transthoracic echocardiography (TTE) that would dictate whether only clinical follow-up is needed (if negative) or catheterization with IVUS (if positive) is needed. If the latter is performed and shows intramural changes with severe narrowing, endovascular intervention, or surgery should be considered, otherwise medical therapy and follow-up would suffice.
32
In the case of severe clinical symptoms, independent of the athletic background of the patient, ECG, TMT, TTE, and CXR should first be performed and followed by cardiac catheterization with IVUS.
Specific Diagnostic Investigations
ECG
The ECG might show the left ventricular volume overload and sometimes ischemic changes, but it is very rarely useful in the primary diagnostic approach of CAVF. Transesophageal echocardiography (TOE) may also be used to obtain information about the fistula. Therefore, intraoperative TOE can greatly contribute to the facilitation of surgical treatment by identifying the origin, the draining points for the fistula, the quantification of valve regurgitation, and finally the efficacy of CAVF obliteration.
33,34
CAVF should normally be suspected when 2D imaging of the main coronary arteries in the parasternal short axis view shows one artery dilated and the other one of normal size.
Coronary Artery Angiography
Angiography is the main diagnostic technique for the precise diagnosis of the fistulae. Cardiac catheterization provides the hemodynamic evaluation of the fistula and remains the modality of choice for defining coronary artery patterns for structure and flow. It can be used for therapeutic embolization with occlusive oils and devices as well.
35
Angiography provides the most detailed anatomy of the fistula giving information about the size, the course, the origin, the presence of any stenosis, and the drainage site, as well as it helps to exclude various anomalies and defects, including but not limited to patent ductus arteriosus, ventricular septal defects with aortic incompetence, and arteriovenous fistulae in the lungs or chest wall. 35 However, in some cases, origin and relation of the CAVF to adjacent structures may be difficult to determine, thus noninvasive techniques may be used as adjunct.
Multidetector Computed Tomography
Multidetector computed tomography (MDCT) is superior to echocardiography in overweight patients, where they allow excellent anatomical delineation, in contrast to echocardiography. The presence or absence of obstruction can be determined with MDCT, and therefore, the likelihood of a coronary steal presentation (►Figs. 2 and 3). A contrast opacification into the receiving chamber/vessel is useful in confirming the CAVF entry site and patency of the shunt.
36-38
Additional Workup
Magnetic Resonance Imaging (MRI)
MRI may help in the confirmation of the diagnosis. It may reveal the detailed anatomy of the CAVF and can be used as an adjuvant noninvasive method in their investigation.
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Myocardial Perfusion Scan
Myocardial perfusion scan can be a useful tool in the assessment of myocardial ischemia related to the CAVF. The radionuclide examinations in general, can dictate whether invasive treatment is required or not. If the patient has limited myocardial ischemia territory (< 10% left ventricular surface area) and is asymptomatic pharmacotherapy is the first-line treatment.
40
Intracoronary Doppler Ultrasound Scan
Intravascular Doppler ultrasonography may provide additional information about the pathophysiology of the fistula.
41
Management
There is general agreement that symptomatic patients should be treated.
3 According to the American College of Cardiology/ American Heart Association (ACC/AHA) guidelines, "percutaneous or surgical closure is a Class I recommendation for large fistulae regardless of symptoms and for small-to moderatesize fistulae with evidence of myocardial ischemia, arrhythmia, ventricular dysfunction, ventricular enlargement, or endarteritis".
42
Some authors recommend closure of CAVF even in asymptomatic patients to prevent fistula-related complications.
6
With regard to children, and in particular those that are more than 3 to 5 years of age, elective closure of any clinically apparent fistula should be performed, even if the patient remains asymptomatic. 18 A very important complication that has been reported in children is late stenosis, secondary to intimal hyperplasia, that increases the risk for myocardial infarction later in life.
18
Taking into consideration that spontaneous closure of the fistula secondary to spontaneous thrombosis has been reported in rare occasions (1-2% of cases), especially in small fistulae in infants younger than 2 years, then the continuous follow-up of these patients is of paramount importance. Coronary Arteriovenous Fistulae Challoumas et al. 5
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In addition, closure of fistulae that arise in the proximal segment of the coronary vessel is highly recommended as this type of fistulae is more likely to become aneurysmal with a high possibility of rupture.
Therapeutic Modalities
Transcatheter Closure TCC avoids surgical intervention and all related complications including surgical stress, bleeding, infections, events related to inflammatory response due to cardiopulmonary bypass, wound healing problems, and general anesthesia adverse events . The TCC technique is indicated when the anatomy of the fistula is favorable for this treatment (e.g., nontortuous vessel, the fistula should be unique with distal narrowing to avoid embolism to the drainage site, distal portion of the fistula should be accessible with the closure device, and there should be no concomitant cardiac disorders requiring additional surgical intervention).
10,36
Vessel tortuosity and lumen caliber appear to be significant limitations in occlusion device delivery, as reported in the small study by Collins et al.
43
TCC was added to the therapeutic approach of fistulae in 1983, after the first successful management of a CAVF with TCC by Reidy and his colleagues on a patient with severe angina. During the treatment, simultaneously coronary angioplasty was performed for critical stenosis of the anterior descending coronary artery plus transcatheter occlusion by detachable balloon in the large distal circumflex coronary artery for a coronary to bronchial fistula.
13,44
The recent introduction of advanced interventional devices has greatly contributed to the increasing use of TCC for the treatment of CAVF.
13, 45 The choice of device and technique depends on the anatomic characteristics of the CAVF as well as the age and the size of the patient, the catheter size that can be used in the patient, the size of the occluded vessel, and the tortuosity of the catheter course to reach the intended point of occlusion. 20 Gianturco and polyester-covered stainless steel coils, detachable balloons, umbrella devices, covered stent polyvinyl alcohol particles, glue, and a combination of these instruments are mainly used in smaller CAVF.
46,47
The Amplatzer (AGA Medical Corporation, Golden Valley, MN) duct occluder is an ideal device for CAVF closure provided the drainage is large enough to allow the passage of the long sheath.
47
The efficacy of TCC is indisputable as various studies strongly support both the efficiency and safety of this technique.
48-50
The cohort study of six patients by Harikrishnan et al revealed very encouraging results with the use of Cook (Cook Medical Inc., Bloomington, IN) coils (arterial approach) and Nitinol Ductal Occluders (venous approach). Complete closure of the fistulae was achieved in all patients.
48
In accordance with these outcomes are the results of the retrospective study of 15 patients by Trehan et al, who reported 86.6% complete closure of the fistulae having used various occlusion devices: conventional metallic coils, floppy tips of coronary angioplasty guidewires, Amplatzer duct occlude, and Amplatzer septal occluder. 49 Reidy et al recommend the TCC of CAVF as treatment of choice, after they showed its efficacy in their study. Satisfactory closure of the fistulae was observed in six of seven patients with the use of different embolization techniques, namely detachable balloon, coaxial embolization with platinum microcoils, a combination of detachable balloon and microcoil, and standard steel coils. In the unsuccessful case, the valve of the detachable balloon was damaged leading to early balloon deflation and a residual fistula. Importantly, there were no associated complications in any patient.
50
In accordance with the opinion that TCC of CAVF should be the therapeutic strategy of choice are many more investigators, largely based on the success rates in various countries reported in the literature (87% in India, 93% in Russia, 87% in the United States, and 97% in the United Kingdom).
13,51-54
Surgical Treatment
The surgical obliteration of the fistula by epicardial and endocardial ligations is the cornerstone of surgical treatment, first described by Biorck in 1947, and remains until now the most effective treatment.
55
Gunnar Biorck and Clarence Crafoord performed the first successful surgical ligation of a pulmonary-to-coronary artery fistula on July 22, 1947, in Surgical Clinic I, at Sabbatsberg Hospital in Stockholm. The patient was a 15-year-old male adolescent with signs and symptoms suggesting a patent ductus arteriosus Botalli. He underwent left postero-lateral thoracotomy by the method of Crafoord with removal of the fifth rib. However, in the area of the ductus arteriosus no thrill was palpable and further exploration revealed an arteriovenous aneurysm on the pulmonary artery which was consistent with an arteriovenous communication between an aberrant branch of the left coronary artery and the pulmonary artery.
55,56
Surgical treatment is generally reserved for single, large, symptomatic fistulae that are present with angina, cardiac decompression, or complications characterized by high-fistula flow, multiple communications, very tortuous pathways, multiple terminations, significant aneurysmal formation, or need for simultaneous distal bypass.
31,57,58
Some authors have reported successful surgical occlusion of CAVF on beating heart off-pump. 9, 59 Ligation of the CAVF may be performed the outside the heart without cardiopulmonary bypass when there is a simple and easily accessible CAVF.
4
Surgical techniques include internal closure of the fistula from within the pulmonary artery or a cardiac chamber, tangential arteriorhaphy for lateral fistulae, distal ligation alone, and proximal and distal ligations. Furthermore, if the coronary circulation has been compromised, ligation and coronary artery bypass grafting (CABG) is performed if necessary along with closure from within the aneurysmal coronary artery. Depending on the anatomical morphology of the fistula and the consequent involvement of the chambers, the most appropriate technique has to be chosen. 8, 15, 60 Apart from the common postoperative complications (bleeding, infections, arrhythmias) postoperative myocardial ischemia may occur in the case of coronary ligation. For this reason intraoperative TOE is essential not only to review the occlusion or treatment of the fistula but also to assess properly the left and right ventricular function. In the case of significant abnormality of the left or right ventricular function, further intervention may be required with CABG surgery (on or off cardiopulmonary bypass).
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Pharmacological
Antianginal therapy addressing the demand and supply mismatch induced by the coronary "steal phenomenon" may be effective for symptom relief.
57,61
Antiplatelet therapy and prophylactic precautions against bacterial endocarditis are highly recommended. 31 In fact, standard endocarditis prophylaxis should be considered in all patients with CAVF regardless of the type of fistula present.
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Prognosis-Operative Risks
In general, patients with CAVF who undergo a closure procedure have an excellent prognosis.
Recurrence rates are as small as 9 to 19% for TCC and 25% in surgical ligation.
51
The prognosis depends on the severity of the shunt and on certain complications that sometimes occur, such as heart failure, pulmonary hypertension, and bacterial endocarditis.
13
Furthermore, even though mortality related to the surgical procedure should remain extremely low, complications involving ischemic ST-changes, myocardial infarctions, arrhythmias, stroke, and recurrences of the fistulae or even failure of the surgical closure have also been reported.
18
Early death can also rarely be the complication of TCC, as reported in the retrospective study by Alekyan et al, where a 4-year-old girl developed femoral artery thrombosis and acute renal failure. Other complications of this study included migration of the coil into the pulmonary artery, femoral artery thrombosis, and perforation of the vessel wall by the guidewire with immediate thrombosis and occlusion of the fistula. 53 Said et al highlight the caution that should be given to perioperative myocardial infarction as it appeared to be a significant factor determining survival rates in their study. Out of the 46 patients that underwent surgical repair of their CAVF, 5 (11%) patients developed postoperative myocardial infarction, showing the importance and relatively high incidence of this serious complication as well as the necessity for intraoperative TOE.
62
After having reviewed individual cases and nonrandomized, observational cohorts of TCC, and surgical correction, Kiefer et al concluded that there are similar rates of residual fistula flow (20-30%) during follow-up after the two techniques, hence, they appear to be equally effective. 63 An important risk factor for postrepair adverse events was found to be drainage of the fistula into the coronary sinus, regardless of the intervention used (surgical or percutaneous).
64,65
Arsmby et al, reviewed the surgical outcomes of 71 patients (81 fistulae), who ranged in age from 6 days to 77 years. There was only one operative death (1.4%) and it was secondary to myocardial infarction. Other complications reported were arrhythmias (five patients), transient ischemic ECG changes (one patient) and stroke (one patient). Follow-up, which ranged from 0.1 to 21.1 years (longest mean 7.2 years), was available in 65 patients (all asymptomatic), and followup imaging studies in only 21 patients (angiography or echocardiography) with complete closure rates between 50 and 100%.
13
The same authors reviewed the outcomes of TCC in 45 patients (range, 5 weeks-71 years) with a successful occlusion rate of 83%. Recatheterization was required in one case whereas procedural complications included transient ischemic ECG changes (four patients), unretrieved device embolization to tricuspid valve or distal pulmonary artery (similar number), myocardial infarction (one patient), and transient atrial arrhythmia (one patient). There was only one procedure-related death (2.2%) due to embolization of a coil to the left circumflex artery that led to left circumflex artery dissection. Follow-up (range, 1 day-4 years) in 42 of the patients showed no late complications and all were asymptomatic. Imaging studies (echocardiography and angiography) at follow-up (33 patients) revealed a complete closure of 91%.
According to the ACC/AHA Guideline, echocardiography every 3 to 5 years may be useful for patients with small CAVF without clinical symptoms to exclude changes/progression of different parameters (size, chamber enlargement, new symptoms, arrhythmias) that may alter management approach (level of evidence: C Ã ).
42
Furthermore, according to the same guidelines, intermediate-and long-term follow-up after repair with either surgery or TCC appears mandatory in cases where the patient still has large, patulous epicardial conduits.
Long-term follow-up is essential because of the possibility of postoperative recanalization, persistent dilatation of the coronary artery and ostium, thrombus formation, calcification, arrhythmias, and myocardial infarction. 16 In other studies where follow-up has been more detailed, small residual leaks following either type of procedure have been reported in approximately 10% of the patients. 65 Patients should also receive antibiotic prophylaxis for any dental, gastrointestinal, or urologic procedure as they remain at risk for developing endocarditis until the flow is totally abolished.
31
Conclusion
CAVF are rare anatomical conditions present in 0.002% of the general population comprising 48.7% of all coronary artery anomalies. Their mechanism of pathology lies upon the coronary "steal phenomenon" and they may be asymptomatic (usually small ones) or manifest with a variety of cardiac-related symptoms. The diagnostic approach includes angiography (main method used), echocardiography, and MDCT. Asymptomatic patients with small CAVF do not require immediate treatment and are managed with regular follow-up, whereas those with symptoms may be treated with either transcatheter approach or surgical ligation depending on the characteristics of the fistula. Both modes of treatment seem to be equally effective and their outcome is continuously assessed with long-term follow-up. The prognosis, which depends on the severity of the fistula, is excellent and the operative risks very low. Nevertheless, operative deaths as well as postoperative myocardial ischemia have been reported. Antibiotic prophylaxis should be given to patients undergoing any dental, gastrointestinal, or urologic procedure after the closure of the fistula until the blood flow is completely abolished for protection from endocarditis. Follow-up is essential as the patient needs to be regularly assessed for early diagnosis of recurrence of the fistula.
